CAPRICOR THERAPEUTICS INC. - COMMON STOCK

Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

02 1月 2025 08:15:00 条件 Nasdaq GlobeNewswire

Capricor Therapeutics to Present at Upcoming Investor Conferences

02 12月 2024 15:15:00 条件 Nasdaq GlobeNewswire

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency

20 11月 2024 08:00:01 条件 Nasdaq GlobeNewswire

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

13 11月 2024 15:01:00 条件 Nasdaq GlobeNewswire

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting

12 11月 2024 08:00:01 条件 Nasdaq GlobeNewswire

Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13

05 11月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

18 10月 2024 15:01:00 条件 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock

17 10月 2024 05:00:00 条件 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

16 10月 2024 15:17:48 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

15 10月 2024 11:27:21 条件 NetDania Notify

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress

11 10月 2024 08:15:00 条件 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

09 10月 2024 08:15:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

04 10月 2024 08:47:23 条件 NetDania Notify

Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress

04 10月 2024 08:15:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

01 10月 2024 08:48:05 条件 NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

30 9月 2024 10:30:56 条件 NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

25 9月 2024 08:45:14 条件 NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

24 9月 2024 08:45:18 条件 NetDania Notify

Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

24 9月 2024 07:00:01 条件 Nasdaq GlobeNewswire

Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024

23 9月 2024 08:25:00 条件 Nasdaq GlobeNewswire